NAGE
Niagen Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$3.17
+1.93%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-9.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | Pamir Ozan · officer: Chief Financial Officer | A-Award | 4,255 | $2.71 |
| Jul 8, 2026 | Lopez Carlos Luis · officer: SVP, General Counsel | A-Award | 2,314 | $2.71 |
| Jul 8, 2026 | Fried Robert N · director, officer: Chief Executive Officer | A-Award | 1,106 | $2.71 |
| Jun 26, 2026 | Ng Wang Yu Gary · director | A-Award | 31,746 | $3.45 |
| Jun 26, 2026 | Jaksch Frank L Jr · director | A-Award | 31,746 | $3.45 |
| Jun 26, 2026 | Rubin Steven D · director | A-Award | 31,746 | $3.45 |
| Jun 26, 2026 | Shahbazi Hamed · director | A-Award | 31,746 | $3.45 |
| Jun 26, 2026 | Patrick Kristin · director | A-Award | 31,746 | $3.45 |
| Jun 26, 2026 | Cohen Ann · director | A-Award | 31,746 | $3.45 |
| Jun 26, 2026 | YU Wing Tak Wendy · director | A-Award | 31,746 | $3.45 |
| Apr 27, 2026 | Fried Robert N · director, officer: Chief Executive Officer | M-Exempt | 20,000 | $2.61 |
| Feb 24, 2026 | Fried Robert N · director, officer: Chief Executive Officer | A-Award | 503,937 | $4.94 |
| Feb 24, 2026 | Lopez Carlos Luis · officer: SVP, General Counsel | A-Award | 41,420 | $4.94 |
| Feb 24, 2026 | Pamir Ozan · officer: Chief Financial Officer | A-Award | 62,131 | $4.94 |
| Nov 17, 2025 | Pamir Ozan · officer: Chief Financial Officer | Purchase | 4,465 | $6.81 |
| Nov 17, 2025 | Pamir Ozan · officer: Chief Financial Officer | Purchase | 2,220 | $6.85 |
| Jul 3, 2025 | Shahbazi Hamed · director | A-Award | 20,000 | $14 |
| Jun 26, 2025 | Patrick Kristin · director | A-Award | 20,000 | $14 |
| Jun 26, 2025 | YU Wing Tak Wendy · director | A-Award | 20,000 | $14 |
| Jun 25, 2025 | Rubin Steven D · director | A-Award | 20,000 | $14 |
| Jun 25, 2025 | Jaksch Frank L Jr · director | A-Award | 20,000 | $14 |
| Jun 25, 2025 | Cohen Ann · director | A-Award | 20,000 | $14 |
| Jun 25, 2025 | Ng Wang Yu Gary · director | A-Award | 20,000 | $14 |
| Apr 9, 2025 | Fried Robert N · director, officer: Chief Executive Officer | M-Exempt | 66,667 | $3.30 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 8, 2026